ArticleBMC cancer2024

Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET.

Robert Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.